UBS Group
SLS icon

UBS Group’s SELLAS Life Sciences SLS Stock Holding History

UBS Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.15M Buy
745,419
+696,692
+1,430% +$3.12M ﹤0.01% 4547
2025
Q4 		$184K Sell
48,727
-36,262
-43% -$70.5K ﹤0.01% 6621
2025
Q3 		$137K Sell
84,989
-224,698
-73% -$400K ﹤0.01% 6907
2025
Q2 		$678K Buy
309,687
+247,456
+398% +$380K ﹤0.01% 5762
2025
Q1 		$67.2K Sell
62,231
-65,590
-51% -$77.9K ﹤0.01% 7352
2024
Q4 		$133K Buy
+127,821
New +$146K ﹤0.01% 6697
2023
Q4 		– Sell
-26
Closed -$43 – 9834
2023
Q3 		$43 Buy
+26
New +$41 ﹤0.01% 9031
2022
Q4 		– Sell
-1,359
Closed -$3K – 11110
2022
Q3 		$3K Buy
+1,359
New +$3.75K ﹤0.01% 9576
2019
Q4 		– Sell
-2,410
Closed -$15K – 8372
2019
Q3 		$15K Buy
+2,410
New +$17.8K ﹤0.01% 6915
2019
Q2 		– Hold
0
– – – 8129
2019
Q1 		– Sell
-99
Closed -$6.88K – 8123
2018
Q4 		$6K Buy
+99
New +$7.67K ﹤0.01% 7490
2018
Q3 		– Sell
-35
Closed -$2.42K – 8243
2018
Q2 		$6K Buy
35
+24
+218% +$6.58K ﹤0.01% 7417
2018
Q1 		$2K Sell
11
-6
-35% -$1.71K ﹤0.01% 7550
2017
Q4 		$7K Buy
17
+11
+183% +$5.32K ﹤0.01% 7241
2017
Q3 		$3K Buy
+6
New +$3.96K ﹤0.01% 7404
2017
Q2 		– Sell
-15
Closed -$13.1K – 7952
2017
Q1 		$14K Buy
15
+14
+1,400% +$23.2K ﹤0.01% 6408
2016
Q4 		$3K Buy
+1
New +$5.82K ﹤0.01% 7427

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group's SLS Position: Q1 2026 in Review

UBS Group increased its SELLAS Life Sciences (SLS) stake by 1,430% in Q1 2026, buying an estimated $3.12M and bringing the position to 745,419 shares worth $3.15M. The position accounts for ﹤0.01% of the portfolio, ranked #4547.

UBS Group first reported a position in SLS in Q4 2016 and has held it in 16 quarters since. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • UBS Group held 745,419 shares of SELLAS Life Sciences worth $3.15M as of Q1 2026.
  • UBS Group bought 696,692 SELLAS Life Sciences shares in Q1 2026, an estimated $3.12M.
  • SELLAS Life Sciences made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #4547 holding.
  • UBS Group first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 16 quarters since.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.